Cargando…
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
BACKGROUND: Metabolic syndrome is a cluster of common cardiovascular risk factors that includes hypertension and insulin resistance. Hypertension and diabetes mellitus are frequent comorbidities and, like metabolic syndrome, increase the risk of cardiovascular events. Telmisartan, an antihypertensiv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174877/ https://www.ncbi.nlm.nih.gov/pubmed/15892894 http://dx.doi.org/10.1186/1475-2840-4-6 |